ALXO - Rega marang bathi kanthi panyesuaian wutah alxoncology.com

Logo korporat perusahaan ALX Oncology (ALXO)

The PEG ratio chart allows for an assessment of the potential of ALX Oncology Holdings (ALXO), considering the colossal pricing power resulting from inelastic demand for the unique evorpacept. The business focuses on the selective blocking of CD47 to protect erythrocytes, while a patent moat provides an advantage in combination therapy. The current 0.00 indicator determines the magnitude of the metric, helping to understand how fairly the market prices in the development rates of this innovative project.

ALXO: Pangali PEG ALX Oncology 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan alxoncology.com (ALXO)

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:ALXO ALX Oncology Holdings Inc.
Produk asli ALX Oncology Holdings

ALX Oncology Holdings (ALXO) focus on CD47 blockade creates significant risks due to low drug portfolio diversification. When analyzing the PEG ratio, an investor compares the current P/E multiple with the earnings growth rate. The value of 0.00 reflects the degree of asset overvaluation relative to its expansion. A metric below one signals that the company is undervalued. This allows for an objective assessment of business resilience amid fierce competition within the oncology sector.

Pesaing ALX Oncology Holdings

ImmunityBio, Inc. (IBRX) - Rasio rega marang wutah bathi resik|Immunocore Holdings - Pangali rega marang bathi tumrap wutah|Janux Therapeutics, Inc. (JANX) - Rega marang bathi kanthi panyesuaian wutah|RCUS: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ZYME (Zymeworks)|TNGX: Pangali PEG|IOVA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah immatics.com|Pangali rega marang bathi tumrap wutah xencor.com (XNCR)|Rasio rega marang bathi tumrap wutah Compass Therapeutics Inc (CMPX)|Pangali rega marang bathi tumrap wutah Replimune Corp REPL|Lyell - Pangali rega marang bathi tumrap wutah|Pangali PEG Innate Pharma S.A IPHA|PYXS - Rasio rega marang bathi tumrap wutah|CGEN (Compugen) - Rasio P/E diaturake wutah|IO Biotech Inc. (IOBT) - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Sutro Bio (STRO)|Pangali rega marang bathi tumrap wutah INKT|HOWL - Rasio rega marang wutah bathi resik|Pangali rega marang bathi tumrap wutah IMMX (Immix Biopharma, Inc.)|CUE (Cue Biopharma) - Koefisien bali modal nimbang wutah|Pangali PEG PDSB (PDS Biotechnology)|Koefisien bali modal nimbang wutah SONN|MAIABiotech.com - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Liminatus|Lava Tx (LVTX) - Rasio rega marang bathi tumrap wutah|NextCure, Inc. - Koefisien bali modal nimbang wutah|LPTX (Leap Tx) - Pangali PEG|Pangali PEG intensitytherapeutics.com|Rasio rega marang bathi tumrap wutah senseibio.com (SNSE)|TOVX: Rasio kapitalisasi marang bathi lan wutah|Gritstone bio - Pangali rega marang bathi tumrap wutah|Kapitalisasi marang bathi resik kanthi nimbang wutah kinetabio.com (KA)|NEXI - Rasio rega marang bathi tumrap wutah|Turnstone Biologics Corp - Rasio nilai perusahaan marang wutah bathi|VCNX: Pangali PEG|Harpoon Therapeutics Corp (HARP) - Pangali PEG